*Trans-IT-BrCa Transfection Reagent, Kit

Protocol

• Broad Spectrum DNA Delivery - Achieve high expression levels in breast cancer cell types including: MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D.
• Formulated for Low Cellular Toxicity - Maintain cell density and reduce experimental biases due to toxicity
• Superior Transfection Efficiency - TransIT®-BrCa outperforms Lipofectamine® 2000, in multiple breast cancer cell lines